nyse:abbv
|
https://www.indeed.com/cmp/pharmacyclics,-an-abbvie-company
|
Aug 29th, 2022 12:00AM
|
Open
|
Pharmacyclics, an AbbVie Company
|
|
Pharmaceutical & Biotechnology
|
Pharmacyclics is an AbbVie company based in Silicon Valley, California and focused on developing and commercializing small-molecule medicines for the treatment of cancers and immune-mediated diseases for which there is great unmet medical need. We seek to discover innovative therapies to improve standards of care and strive to help our patients rediscover the Magic of Normal.
Pharmacyclics is committed to the development and commercialization of novel therapies intended to improve the quality and duration of life and to resolve serious unmet medical needs for cancer patients. Pharmacyclics is a wholly-owned subsidiary of AbbVie (NYSE:ABBV), a global, research-based biopharmaceutical company. Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products and a pipeline containing multiple promising new molecules that are being studied in more than 200 clinical trials for over 20 different types of cancer.
More than 1,200 Pharmacyclics and AbbVie research scientists, clinicians, marketing, operations, and corporate professionals work in the San Francisco Bay Area. They combine their expertise in immuno-oncology, stem cells, and cell-signaling with their knowledge of bispecific antibodies, antibody-drug conjugates (ADCs), and covalent-inhibitor technologies to discover and develop novel cancer treatments. Together, we are striving to outsmart cancer.
|
RRv1_100M_500M
|
999 E. Arques Ave Sunnyvale, California 94085
|
|
|
|
3.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41.00
|
41.00
|
2.70
|
3.40
|
2.70
|
2.50
|
2.90
|
12.00
|
About two weeks
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 12:51PM
|
Aug 29th, 2022 12:51PM
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
https://www.indeed.com/cmp/forest-pharmaceuticals
|
Aug 29th, 2022 12:00AM
|
Open
|
Forest Pharmaceuticals
|
|
|
|
|
|
|
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
138.00
|
138.00
|
3.40
|
3.70
|
3.10
|
3.30
|
3.50
|
|
|
|
|
|
|
|
|
|
Aug 29th, 2022 12:51PM
|
Aug 29th, 2022 12:51PM
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
https://www.indeed.com/cmp/abbvie
|
Aug 29th, 2022 12:00AM
|
Open
|
AbbVie
|
|
Pharmaceutical & Biotechnology
|
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
|
RRv1_OVER_10B
|
North Chicago, Illinois
|
Richard A. Gonzalez
|
|
|
3.90
|
71.0
|
68.0
|
72.0
|
69.0
|
65.0
|
64.0
|
63.0
|
71.0
|
62.0
|
65.0
|
64.0
|
70.0
|
71.0
|
433.0
|
1224
|
1200
|
3.70
|
4.00
|
3.40
|
3.40
|
3.70
|
286.00
|
About a week
|
329.00
|
MEDIUM
|
323.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 12:51PM
|
Aug 29th, 2022 12:51PM
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
https://www.indeed.com/cmp/zeltiq-aesthetics
|
Aug 29th, 2022 12:00AM
|
Open
|
Zeltiq Aesthetics
|
|
|
Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ) is a global medical equipment supplier. The company's products include the CoolSculpting System which is used to do lipolysis, and Cryolipolysis as well as non-invasive technologies for plastic surgery. Cryolipolysis is an owned trademark of the company and it refers to equipment to destroy fat cells. The company has clearance from the U.S. Food and Drug Administration.
|
RRv1_100M_500M
|
Pleasanton
|
|
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16.00
|
16.00
|
3.60
|
4.20
|
3.20
|
3.40
|
3.70
|
|
|
5.00
|
MEDIUM
|
5.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 12:51PM
|
Aug 29th, 2022 12:51PM
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
https://www.indeed.com/cmp/allergan
|
Aug 29th, 2022 12:00AM
|
Open
|
Allergan
|
|
Pharmaceutical & Biotechnology
|
Allergan plc (NYSE: AGN), is a bold, global pharmaceutical company. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.
Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories.
Allergan is an industry leader in Open Science, the Company’s R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. This approach has led to Allergan building one of the broadest development pipelines in the pharmaceutical industry with 70+ mid-to-late stage pipeline programs in development.
Our Company’s success is powered by our more than 16,000 global colleagues’ commitment to being Bold for Life. Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world by always doing what is right.
With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day.
For more information, visit Allergan’s website at www.Allergan.com.
|
RRv1_1B_5B
|
Dublin, Ireland
|
Brent Saunders
|
|
|
3.80
|
69.0
|
63.0
|
64.0
|
67.0
|
63.0
|
61.0
|
58.0
|
67.0
|
57.0
|
61.0
|
61.0
|
65.0
|
69.0
|
202.0
|
1337
|
1300
|
3.50
|
3.90
|
3.30
|
3.40
|
3.70
|
122.00
|
About a week
|
134.00
|
MEDIUM
|
137.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 12:51PM
|
Aug 29th, 2022 12:51PM
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
https://www.indeed.com/cmp/pharmacyclics,-an-abbvie-company
|
Aug 28th, 2022 12:00AM
|
Open
|
Pharmacyclics, an AbbVie Company
|
|
Pharmaceutical & Biotechnology
|
Pharmacyclics is an AbbVie company based in Silicon Valley, California and focused on developing and commercializing small-molecule medicines for the treatment of cancers and immune-mediated diseases for which there is great unmet medical need. We seek to discover innovative therapies to improve standards of care and strive to help our patients rediscover the Magic of Normal.
Pharmacyclics is committed to the development and commercialization of novel therapies intended to improve the quality and duration of life and to resolve serious unmet medical needs for cancer patients. Pharmacyclics is a wholly-owned subsidiary of AbbVie (NYSE:ABBV), a global, research-based biopharmaceutical company. Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products and a pipeline containing multiple promising new molecules that are being studied in more than 200 clinical trials for over 20 different types of cancer.
More than 1,200 Pharmacyclics and AbbVie research scientists, clinicians, marketing, operations, and corporate professionals work in the San Francisco Bay Area. They combine their expertise in immuno-oncology, stem cells, and cell-signaling with their knowledge of bispecific antibodies, antibody-drug conjugates (ADCs), and covalent-inhibitor technologies to discover and develop novel cancer treatments. Together, we are striving to outsmart cancer.
|
RRv1_100M_500M
|
999 E. Arques Ave Sunnyvale, California 94085
|
|
|
|
3.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41.00
|
41.00
|
2.70
|
3.40
|
2.70
|
2.50
|
2.90
|
12.00
|
About two weeks
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 05:52AM
|
Aug 28th, 2022 05:52AM
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
https://www.indeed.com/cmp/zeltiq-aesthetics
|
Aug 28th, 2022 12:00AM
|
Open
|
Zeltiq Aesthetics
|
|
|
Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ) is a global medical equipment supplier. The company's products include the CoolSculpting System which is used to do lipolysis, and Cryolipolysis as well as non-invasive technologies for plastic surgery. Cryolipolysis is an owned trademark of the company and it refers to equipment to destroy fat cells. The company has clearance from the U.S. Food and Drug Administration.
|
RRv1_100M_500M
|
Pleasanton
|
|
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16.00
|
16.00
|
3.60
|
4.20
|
3.20
|
3.40
|
3.70
|
|
|
5.00
|
MEDIUM
|
5.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 05:52AM
|
Aug 28th, 2022 05:52AM
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
https://www.indeed.com/cmp/abbvie
|
Aug 28th, 2022 12:00AM
|
Open
|
AbbVie
|
|
Pharmaceutical & Biotechnology
|
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
|
RRv1_OVER_10B
|
North Chicago, Illinois
|
Richard A. Gonzalez
|
|
|
3.90
|
71.0
|
68.0
|
72.0
|
69.0
|
65.0
|
64.0
|
63.0
|
71.0
|
62.0
|
65.0
|
64.0
|
70.0
|
71.0
|
433.0
|
1224
|
1200
|
3.70
|
4.00
|
3.40
|
3.40
|
3.70
|
286.00
|
About a week
|
329.00
|
MEDIUM
|
323.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 05:52AM
|
Aug 28th, 2022 05:52AM
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
https://www.indeed.com/cmp/allergan
|
Aug 28th, 2022 12:00AM
|
Open
|
Allergan
|
|
Pharmaceutical & Biotechnology
|
Allergan plc (NYSE: AGN), is a bold, global pharmaceutical company. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.
Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories.
Allergan is an industry leader in Open Science, the Company’s R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. This approach has led to Allergan building one of the broadest development pipelines in the pharmaceutical industry with 70+ mid-to-late stage pipeline programs in development.
Our Company’s success is powered by our more than 16,000 global colleagues’ commitment to being Bold for Life. Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world by always doing what is right.
With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day.
For more information, visit Allergan’s website at www.Allergan.com.
|
RRv1_1B_5B
|
Dublin, Ireland
|
Brent Saunders
|
|
|
3.80
|
69.0
|
63.0
|
64.0
|
67.0
|
63.0
|
61.0
|
58.0
|
67.0
|
57.0
|
61.0
|
61.0
|
65.0
|
69.0
|
202.0
|
1337
|
1300
|
3.50
|
3.90
|
3.30
|
3.40
|
3.70
|
122.00
|
About a week
|
134.00
|
MEDIUM
|
137.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 05:52AM
|
Aug 28th, 2022 05:52AM
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
https://www.indeed.com/cmp/forest-pharmaceuticals
|
Aug 28th, 2022 12:00AM
|
Open
|
Forest Pharmaceuticals
|
|
|
|
|
|
|
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
138.00
|
138.00
|
3.40
|
3.70
|
3.10
|
3.30
|
3.50
|
|
|
|
|
|
|
|
|
|
Aug 28th, 2022 05:52AM
|
Aug 28th, 2022 05:52AM
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|